-
Mashup Score: 0
A study found higher daily temperatures increased anaphylaxis risk, except for cases related to medical procedures, highlighting heat’s role in allergic reactions.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Clinical Quiz: Anaphylaxis Management and Epinephrine Use - 9 day(s) ago
In this quiz, we test your knowledge of evidence-based management strategies, recommended epinephrine doses, and evolving guidance on patient follow-up and discharge planning for anaphylaxis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Fancy yourself an #allergy expert? Test your knowledge of the 2023 ACAAI anaphylaxis practice update in our latest clinician quiz! https://t.co/IiDjE9P0kl #AAAAI25 #Anaphylaxis https://t.co/5u56FnvRyh
-
-
Mashup Score: 0
This approval by the FDA of Evolus’s 2 new hyaluronic acid gels provides an additional set of options for dermatologists in the aesthetic products market.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
An announcement has been published by Evolus, Inc., that the #FDA has approved 2 injectable hyaluronic acid gels titled ‘Evolysse Form’ and ‘Evolysse Smooth.’ View more here: https://t.co/AlG1oUcwoV #skincare #dermatology https://t.co/nMsjmOEOd6
-
-
Mashup Score: 0
A study found the Skin Barrier Meter accurately measures skin barrier function in children with atopic dermatitis, offering a fast, non-invasive assessment within 5 seconds.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
📢 New study finds the portable Skin Barrier Meter accurately and safely measures skin barrier function in kids with atopic dermatitis in just 5 seconds. Findings will be presented at #AAAAI2025. #AtopicDermatitis #Dermatology #SkinHealth Read more: https://t.co/cTd0lGwC5F
-
-
Mashup Score: 1
In these new findings, investigators highlight phase 1 research into ritlecitinib for patients aged 6 to 12 years with alopecia areata.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
In #dermatology news: Treatment of #AlopeciaAreata with ritlecitinib 20 mg once daily for 7 days may be considered generally well tolerated among patients aged 6 to < 12 years years, according to recent data. View more 👇 https://t.co/bppMy0FkrR
-
-
Mashup Score: 0
Patients with adenomas had a greater risk of colorectal cancer, and advanced adenomas were linked to a greater risk of cancer-related and all-cause mortality.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
New research points to a heightened risk of colorectal #cancer in patients with both nonadvanced and advanced adenomas detected during #colonoscopy. Advanced adenomas were also linked to a greater risk of both cancer-related and all-cause mortality. https://t.co/Xpy8YPzJyZ
-
-
Mashup Score: 2
Weisinger discussed findings from the largest cohort of patients with iTTP treated with Obinutuzumab.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
HCPLive spoke with Julia Weisinger, MD, about findings from the largest cohort of patients with iTTP treated with obinutuzumab at #ASH24. Watch now: https://t.co/q0IdbB05Aq
-
-
Mashup Score: 13
Olpasiran sustained reductions in oxidized phospholipids on apoB in patients with ASCVD and elevated Lp(a) levels in the Phase 2 dose-ranging trial.
Source: www.hcplive.comCategories: General Medicine News, Partners & KOLsTweet-
Olpasiran Reduces Oxidized Phospholipids on ApoB in OCEAN(a)-DOSE Trial - HCPLive - https://t.co/iabj2nLJYO @Lpa_Doc
-
-
Mashup Score: 0GLP-1 RAs Linked to Lower Cardiovascular Morbidity, All-Cause Mortality Risk in MASLD - 9 day(s) ago
GLP-1 RA use was associated with a lower risk of major cardiovascular events, clinically significant portal hypertension, and all-cause mortality in MASLD.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
New research suggests use of GLP-1 RAs is associated with a reduced risk of major cardiovascular events, clinically significant portal hypertension, new-onset HF, and all-cause mortality in patients with #MASLD. Learn more: https://t.co/mZSvxQu2G7
-
-
Mashup Score: 2Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD - 10 day(s) ago
Bruckner discusses her team’s long-term data on the safety and efficacy of birch bark extract, also known as Oleogel-S10, for those with epidermolysis bullosa.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
In a new interview🎥 The phase 3 EASE study on long-term use of birch triterpenes (Filsuvez) for #EpidermolysisBullosa was discussed. We interviewed Anna Bruckner, MD, of @ChildrensColo & @CUAnschutz, highlighting new research on this serious condition. https://t.co/MNgtvbClrP https://t.co/pRAhz5S7ec
-
🌡️🔥 Extreme heat may heighten #anaphylaxis risk—excluding cases tied to medical procedures. A study found a 49% increased risk of hospitalization on high temperature days. https://t.co/5XSYwMaDEX https://t.co/ldZPZ4cfLm